Abstract 2064P
Background
Hospitalisation is an inevitable step in the evolution of many patients with cancer, principally in advanced tumors. This study aims to describe the admissions to a medical oncology inpatient service of our University Hospital between November 2022 and April 2023.
Methods
We conducted a retrospective cross-sectional study of patients admitted to the Medical Oncology Service of Infanta Sofía University Hospital (Madrid) along six months. Database was collected from the electronic health records. The following variables were analyzed: age, sex, type of tumor, stages, origin of the admission, period of hospital stay, diagnoses, assessment by another specialities, type of discharge and readmissions.
Results
In the chosen period, 310 hospitalisations related to 223 patients were studied, because some of them were readmitted in these six months. The average age was 71.49 years, 42.9% women and 57.1% men. The average hospital stay was 10.18 days. Near 77% of the patients had advanced disease. In order of frequency, patients with lung (28.06%), colorectal (15.8%) and genitourinary (11.94%) cancer represented the most of inpatients. Mainly the patients were admitted from the Emergency Department of our Hospital (56.45%). The most prevalent reason for hospitalisation was secondary symptoms of disease progression. Infections were the cause of admission in 24.52% of the cases and 27.42% of them were from respiratory system. Other causes to take into account were the toxicity to the treatment (5.8%). As part of the multidisciplinary approach, during their hospitalisation, 5.26% inpatients required surgical assessment. Interventional radiologists treated 1.29% patients and endocrinologists providing nutritional support in 10.65% of cases. Furthermore, less than 2% of our patients were admitted to the Intensive Care Unit. Palliative Care Unit assessed 37.74% of the inpatients, which 19.35% were being previously followed-up by them. Unfortunately 15.8% of the admitted patients died. We also observed 26.45% had to be admitted again.
Conclusions
It is important to identify the reasons why patients with cancer are admitted to the Hospital because it could help to identify areas for improvement in the quality of care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2086P - Management of opioids use disorder in cancer survivors
Presenter: Khalida Berkane
Session: Poster session 06
2087P - Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management
Presenter: Raffaele Giusti
Session: Poster session 06
2088P - Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists
Presenter: Anna Amela Valsecchi
Session: Poster session 06
2090P - Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
Presenter: Luca Licata
Session: Poster session 06
2091P - Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
Presenter: Pascale Dielenseger
Session: Poster session 06
2092P - Bone loss in premenopausal Algerian women treated with chemotherapy for early-stage of breast cancer: Evaluation by DXA and identification of associated risk factors
Presenter: MACHEROUM Fatma zohra
Session: Poster session 06
2093P - Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy
Presenter: SangUk Han
Session: Poster session 06
2094P - A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
Presenter: Shinya Takada
Session: Poster session 06
2095P - Cancer rehabilitation program for cancer-related fatigue
Presenter: Aizhan Bekisheva
Session: Poster session 06